Agnico Eagle Mines has given back much of its recent rally in a matter of days — down 12% on the week to $173.40, erasing the gains that prompted last week's note on short sellers retreating.
The reversal is sector-wide, not stock-specific. Close peers have moved in lockstep with AEM. Kinross Gold dropped 13.3% on the week. Centerra Gold fell 13.2%. AngloGold Ashanti led to the downside at -14.4%, while Equinox Gold shed 17.1%. The only relative outperformer in the peer group was Franco-Nevada, down a more modest 6%. The message is uniform: this is a gold-price-driven flush, not an AEM-specific dislocation.
The positioning picture remains remarkably calm given the scale of the move. Short interest barely budged — it held near 0.9% of free float, essentially unchanged from last week's already-low level. That rules out short sellers as the driver of the decline. Cost to borrow eased further to 0.36% APR, its lowest reading in the 30-day window, down from around 0.55% a fortnight ago. Borrow availability is maximally loose, with no sign of any demand building to re-establish short positions despite the price drop. Options positioning is similarly relaxed: the put/call ratio of 0.63 sits almost exactly on its 20-day average of 0.63, with a z-score effectively at zero. There is no hedging surge, no crowding of downside protection — markets are treating the pullback as orderly.
The Street remains structurally bullish, though the gap between analyst targets and the current price has widened sharply. The consensus mean target is $259, implying roughly 49% upside from $173. The most recent action was JP Morgan in early May, maintaining Neutral while nudging its target up to $222 — still well above the current price. CIBC holds Outperform with a $304 target, though that was set before the sell-off gathered pace. The bull case centres on the post-2022 Kirkland Lake merger delivering operational leverage and an estimated 15 years of gold reserves; bears point to valuation vulnerability if gold prices retrace, flagging a downside scenario around $80 per share in a sustained low-gold-price environment. With the P/E multiple now at 12.3x — having compressed by 3.6 points over 30 days — and EV/EBITDA at 6.8x, the stock is repricing toward the cheaper end of its recent range. The dividend score ranks at a perfect 100 in ORTEX factor data, and EPS momentum over 30 days remains solid at the 71st percentile, suggesting underlying earnings momentum has not yet deteriorated to match the price action.
Institutional flows add a layer of interest. Van Eck — the gold-specialist ETF manager — added nearly 4 million shares in the April reporting period, a meaningful addition for a fund of that mandate. BlackRock added 144,000 shares and Capital Research added 904,000. The one notable trimmer in the top-15 holder list was Arrowstreet Capital, which reduced by nearly 1.9 million shares. Insiders sold consistently in late 2025 and early 2026, including the CEO and CFO, though those sales occurred at prices between $231 and $338 — well above current levels — making them less informative about conviction at today's prices.
The next earnings event is scheduled for July 29. The most recent print on May 1 produced a 4.4% one-day decline followed by a 2.7% five-day recovery — a pattern worth holding in mind as the stock approaches that date in a materially weaker position than it did the last time around. What to watch is whether the gold-price pullback stabilises and whether peer divergence — particularly Franco-Nevada's relative resilience — reflects genuine quality rotation or simply a royalty-model premium reasserting itself under pressure.
See the live data behind this article on ORTEX.
Open AEM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
